Effect of obesity on survival of women with epithelial ovarian cancer: A systematic review and meta-analysis of observational studies

International Journal of Gynecological Cancer

Volumn 21, Issue 9, 2011, Pages 1525-1532

  Yang, Hyun Sik ^a,d   Yoon, Chan ^b,d   Myung, Seung Kwon ^c   Park, Sang Min ^d  

^a Muju Health Center and County Hospital   (South Korea)

^b Hwasung Public Health Center   (South Korea)

^c National Cancer Center   (South Korea)

^d Seoul National University Hospital   (South Korea)

Author keywords

Meta analysis; Obesity; Ovarian carcinoma; Prognosis; Survival

Indexed keywords

ADULTHOOD; ADVANCED CANCER; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; COCHRANE LIBRARY; COHORT ANALYSIS; EMBASE; EPITHELIAL OVARY CANCER; FEMALE; HUMAN; MEDLINE; META ANALYSIS (TOPIC); MORBID OBESITY; OBESITY; OBSERVATIONAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SYSTEMATIC REVIEW (TOPIC); ADULT; AGE; META ANALYSIS; MORTALITY; NEOPLASM; OBSERVATION; OVARIAN EPITHELIAL CANCER; OVARY TUMOR;

ADULT; AGE FACTORS; COHORT STUDIES; FEMALE; HUMANS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OBESITY; OBSERVATION; OVARIAN NEOPLASMS; YOUNG ADULT;

EID: 84863266838     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31822eb5f8     Document Type: Review

References (25)

1. Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol. 2006;20:207-225. (Pubitemid 43380597)
2. McGuire V, Jesser CA, Whittemore AS, et al. Women with invasive epithelial ovarian cancer. Gynecol Oncol. 2002;84:399-403. (Pubitemid 34211865)
3. Markmann S, Gerber B, Briese V. Prognostic value of Ca 125 levels during primary therapy. Anticancer Res. 2007;27:1837-1839. (Pubitemid 46954684)
4. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:1-253; i-xii.
5. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4:579-591. (Pubitemid 39025053)
6. Olsen CM, Green AC, Whiteman DC, et al. Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. Eur J Cancer. 2007;43:690-709. (Pubitemid 46502901)
7. Schildkraut JM, Halabi S, Bastos E, et al. Prognostic factors in early-onset epithelial ovarian cancer: a population-based study. Obstet Gynecol. 2000;95:119-127. (Pubitemid 30001641)
8. Nagle CM, Purdie DM, Webb PM, et al. Dietary influences on survival after ovarian cancer. Int J Cancer. 2003;106:264-269. (Pubitemid 36835181)
9. Zhang M, Xie X, Lee AH, et al. Body mass index in relation to ovarian cancer survival. Cancer Epidemiol Biomarkers Prev. 2005;14:1307-1310. (Pubitemid 40656486)
10. Kjaerbye-Thygesen A, Frederiksen K, Hogdall EV, et al. Smoking and overweight: negative prognostic factors in stage III epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2006;15:798-803.
11. Pavelka JC, Brown RS, Karlan BY, et al. Effect of obesity on survival in epithelial ovarian cancer. Cancer. 2006;107:1520-1524. (Pubitemid 44546912)
12. Hess LM, Barakat R, Tian C, et al. Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2007;107:260-265. (Pubitemid 47575723)
13. Li AJ, Elmore RG, Pavelka JC, et al. Hyperandrogenism, mediated by obesity and receptor polymorphisms, promotes aggressive epithelial ovarian cancer biology. Gynecologic Oncology. 2007;107:420-423. (Pubitemid 350176558)
14. Moysich KB, Baker JA, Menezes RJ, et al. Usual adult body mass index is not predictive of ovarian cancer survival. Cancer Epidemiol Biomarkers Prev. 2007;16:626-628. (Pubitemid 46548673)
15. Barrett SV, Paul J, Hay A, et al. Does body mass index affect progression-free or overall survival in patients with ovarian cancer? Results from SCOTROC I trial. Ann Oncol. 2008;19:898-902. (Pubitemid 351627304)
16. Munstedt K, Wagner M, Kullmer U, et al. Influence of body mass index on prognosis in gynecological malignancies. Cancer Causes Control. 2008;19:909-916.
17. Skirnisdottir I, Sorbe B. Prognostic impact of body mass index and effect of overweight and obesity on surgical and adjuvant treatment in early-stage epithelial ovarian cancer. Int J Gynecol Cancer. 2008;18:345-351. (Pubitemid 351365212)
18. Yang L, Klint A, Lambe M, et al. Predictors of ovarian cancer survival: a population-based prospective study in Sweden. Int J Cancer. 2008;123:672-679. (Pubitemid 351898427)
19. Matthews KS, Straughn JM, Jr, Kemper MK, et al. The effect of obesity on survival in patients with ovarian cancer. Gynecol Oncol. 2009;112:389-393.
20. Skirnisdottir I, Sorbe B. Body mass index as a prognostic factor in epithelial ovarian cancer and correlation with clinico-pathological factors. Acta Obstet Gynecol Scand. 2010;89:101-107.
21. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157-163.
22. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-1558. (Pubitemid 34746062)
23. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188. (Pubitemid 17189972)
24. Sterne JA, Egger M, Smith GD. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ. 2001;323:101-105. (Pubitemid 32681979)
25. Olsen CM, Nagle CM. Body mass index is not predictive of ovarian cancer survival. South Med J. 2008;101:1079.